All Updates

All Updates

icon
Filter
Partnerships
BioAI partners with Genomic Testing Cooperative to develop AI-enabled digital pathology services for oncology
Precision Medicine
Jun 25, 2024
Last week:
Product updates
Eve Air Mobility unveils unmanned eVTOL prototype
Passenger eVTOL Aircraft
Yesterday
Product updates
Lilium advances POWER-ON, providing solutions with leading digital innovators
Passenger eVTOL Aircraft
Yesterday
Industry news
New South Korean space agency provides rundown of plans
Space Travel and Exploration Tech
Jul 20, 2024
Management news
Bionano Genomics receives Nasdaq non-compliance notice; continues trading efforts
Precision Medicine
Jul 19, 2024
Funding
GRO Biosciences raises USD 60.3 million in Series B funding to advance lead program into clinical trials and expand GRObio pipeline
Precision Medicine
Jul 19, 2024
Management news
Yooz announces new appointments in C-Suite
Business Expense Management
Jul 19, 2024
Regulation/policy
Airwallex secures license to expand retail investment offerings in Australia
FinTech Infrastructure
Jul 19, 2024
Partnerships
EHang collaborates with KC Smart Mobility to expand EH216-S sales and operations in China
Passenger eVTOL Aircraft
Jul 19, 2024
Industry news
China launches Gaofen-11 high-resolution intelligence satellite
Satellite Management
Jul 19, 2024
Industry news
France funds miniature satellite capture and inspection mission
Satellite Management
Jul 19, 2024
Precision Medicine

Precision Medicine

Jun 25, 2024

BioAI partners with Genomic Testing Cooperative to develop AI-enabled digital pathology services for oncology

Partnerships

  • BioAI Health and Genomic Testing Cooperative (GTC) have partnered to leverage their AI capabilities to create advanced solutions for oncology diagnostics and clinical research. Under the partnership, GTC will become an early technology access member of BioAI's global clinical laboratories.

  • The collaboration involves GTC providing BioAI access to its characterized imaging data, enabling BioAI to refine and develop its AI algorithms. It also focuses on the joint development of genomic biomarker screening algorithms and assays for use in clinical settings and introduces a range of diagnostic solutions, including screening tests and comprehensive genomic profiling using DNA and RNA for tissue and liquid biopsies.

  • BioAI Health is a biotechnology company that leverages advanced AI for precision medicine. It focuses on mapping the causal biology of diseases, developing digital biomarkers, and identifying novel drug targets. Its key offerings include AI-driven biomarker services, drug discovery, and data sourcing. BioAI uses technological platforms such as PredictX and In-Silico Phenotype Projection to enhance genetic mutation identification and drug target discovery, helping to accelerate the clinical R&D process.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.